Why the study?
Do propranolol, methyldopa, and bendrofluazide have different effects on plasma noradrenaline and plasma renin activity in hypertensive patients?
Do propranolol, methyldopa, and bendrofluazide have different effects on plasma noradrenaline and plasma renin activity in hypertensive patients?
Answers are grounded in this paper and cite their sources.
Different antihypertensive drugs have distinct effects on the sympathetic nervous system and renin-angiotensin system, which may guide long-term therapy choices.
Plasma noradrenaline and plasma renin activity were measured as indices of sympathetic activity and renin angiotensin system in similar groups of hypertensive patients receiving either propranolol, bendrofluazide or methyldopa. Plasma renin activity was similar in the propranolol and methyldopa groups and significantly lower (p less than 0.01) in both these groups than the diuretic treated subjects. Plasma noradrenaline was significantly lower (p less than 0.01) on methyldopa than either propranolol or bendrofluazide. These different effects on the renin angiotensin system and the sympathetic nervous system of these drugs may be relevant in the choice of long term therapy in hypertension.
No takes yet. Share an insight, caveat, or question.
Polák et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: